期刊文献+

miRNAs在甲状腺乳头状癌中的表达及临床病理意义 被引量:4

Expression of specific miRNAs in papillary thyroid carcinomas and their clinicopathological significance
暂未订购
导出
摘要 目的探讨甲状腺乳头状癌(PTC)中特征性的miRNA表达谱以及临床病理意义。方法对52例PTC及7例良性甲状腺肿瘤手术切除标本采用基因芯片技术及RNA印迹杂交法检测miRNA的表达,对过表达的miRNA表达水平与PTC临床病理特征之间的关系进行分析。结果 (1)用基因芯片技术筛检发现PTC组织中5例过表达的miRNAs(miR-375、miR-34a、miR-146b、miR-222、miR-31)。(2)RNA印迹杂交法验证芯片结果及检测其他miRNAs结果显示:miR-34a、miR-146b、miR-31、miR-21和miR-221在PTC组织中的表达水平较癌旁正常甲状腺组织显著升高(P<0.05)。MiR-146b和miR-221在PTC组织中的过表达率较良性甲状腺肿瘤组织显著升高(P<0.01)。PTC患者中包膜侵犯组、淋巴结转移组、TNM分期Ⅲ-Ⅵ期组及AGES系统评分≥5分组miR-221的表达水平均明显高于相应对照组(P<0.05或0.01);而男性PTC患者的miR-146b表达水平明显高于女性PTC患者(P<0.05)。结论 miR-146b、miR-221、miR-21和miR-31的过表达与PTC的发生、发展有关;过表达的miR-221和miR-146b与PTC的预后不良有关。 Objective To investigate expression of specific miRNAs in papillary thyroid carcinoma (PTC) and their clini-copathological significance. Methods Fifty two surgical specimens of PTC tissues and 7 specimens of benign thyroid tumor tis-sues were col ected. The miRNA expression levels were detected by using microarray and Northern blot. The correlation between over- expressed miRNAs and clinicopathological features of PTC were analyzed. Results A set of 5 over- expressed miRNAs (miR- 375, miR- 34a, miR- 146b, miR- 222, miR- 31) was distinguished by microarray in PTC tissues compared to cancer- adja-cent tissues. Using Northern blot, the results of microarray were verified;and Northern blot results also showed that the expres-sion levels of miR- 34a, miR- 146b, miR- 31, miR- 221 and miR- 21 in PTC were significantly higher than those in cancer- adjacent tissues(P〈0.05). Additional y, the over- expression rates of miR- 146b and miR- 221 in PTC tissues were significantly higher than those in benign thyroid tumor tissues (P〈0.01). The expression levels of miR- 221 in PTC patients with extrathyroidal invasion, lymph node metastasis, advanced TNM stage (III- IV) and AGES score≥5 were significantly higher than those in control groups (P〈0.05 or 0.01);whereas the expression level of miR- 146b in male PTC patients was significantly higher than that in female PTC patients (P〈0.05). Conclusion Over- expression of miR- 146b, miR- 221, miR- 21, and miR- 31 may be associated with car-cinogenesis and progression of PTC, and the over- expression of miR- 221 and miR- 146b are also correlated with poor clinical outcome of PTC patients.
出处 《浙江医学》 CAS 2013年第20期1802-1806,共5页 Zhejiang Medical Journal
基金 浙江省自然科学基金资助项目(Y13H160115)
关键词 甲状腺乳头状癌 微小RNA 芯片 RNA印迹杂交法 Papillary thyroid carcinoma MiRNAs Microarray Northern blot
  • 相关文献

参考文献23

  • 1Ambros V. The functions of animal microRNAs[J]. Nature, 2004 431:350-355.
  • 2Nix P, Nicolaides A, Coatesworth A P, Thyroid cancer review 1 presentation and investigation of thyroid cancer[J]. Int J Clin Pract 2005, 59(11):1459-1463.
  • 3Lubina A, Cohen O, Baechana M, et al. Time trends of incidence rates of thyroid cancer in Israel: what might explain the sharp in- crease[J]. Thyroid, 2006, 16(10): 1033-1040.
  • 4Kutay HI Bai S, Datta J, et al. Downregulation of miR-122 in the rodent and human hepatocellular carcinomas[J]. J Cell Biochem, 2006, 99(3): 671-678.
  • 5He H, Jazdzewski K, Li W, et al. The role of microRNA genes in papillary thyroid carcinoma[J]. PNAS, 2005, 102:19075-19080.
  • 6Sheu S Y, Grabellus F, Schwertheim S, et aL Differential miRNA expression profiles in variants of papillary thyroid carcinoma and encapsulated follicular thyroid tumours[J]. Br J Cancer, 2010, 102 (2):376-382.
  • 7Tetzlaff M T, Liu A, Xu X, et al. Differential expression of miRNAs in papillary thyroid carcinoma compared to multinodular goiter using formalin fixed paraffin embedded tissues[J]. Endocr Pathol, 2007, 18(3): 163-173.
  • 8Samaan N A, Schultz P N, Hickey R C, et al. The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patients[J]. J Clin Endocrinol Metab, 1992, 75(3):714-720.
  • 9Simon D, Goretzki P E, Witte J, et al. Incidence of regional recur- rence guiding radicality in differentiated thyroid carcinoma [J]. World J Surg, 1996, 20(7): 860-866.
  • 10Loh K C, Greenspan F S, Gee L, et al. Pathological tumor-node- metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients[J]. J Clin Endocrinol Metab, 1997, 82(11 ):3553-3562.

二级参考文献6

  • 1Gemsenjager E,Heitz PU,Seifert B,et al.Differentiated thyroid carcinoma.Follow-up of 264 patients from one institution for up to 25 years[J].Swiss Med Wkly,2001,131(11-12):157-163.
  • 2Rao RS,Parikh DM,Mistry RC,et al.Evidence-based protocols for the management of well-differentiated carcinomas of the thyroid[J].Asian J Surg,2002,25(4):319-324.
  • 3Chow TL,Lim BH,Kwok SP.Sentinel lymph node dissection in papillary thyroid carcinoma[J].ANZ J Surg,2004,74(1-2):10-12.
  • 4McGriff NJ,Csako G,Gourgiotis L,et al.Effects of thyroid hormone suppression therapy on adverse clinical outcomes in thyroid cancer[J].Ann Med,2002,34(7-8):554-564.
  • 5吕平,吕坤章,王春友,陈道达,陈振勇,陈万新.分化型甲状腺癌的外科治疗:167例回顾分析[J].中国普通外科杂志,2002,11(5):259-262. 被引量:12
  • 6余建军,傅西林,张连郁,刘经祖,李树玲.甲状腺乳头状癌的生长与女性激素受体及血清激素水平相关的研究[J].中国肿瘤临床,1992,19(1):14-17. 被引量:16

共引文献8

同被引文献58

  • 1Ferlay J,Shin H R,Bray F,et al.Estimates of worldwide burden of cancer in 2008:GLOBOCAN 2008[J].Int J Cancer,2010,127(12):2893-2917.
  • 2Baloch Z W,Livolsi V A,Asa S L,et al.Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions:a synopsis of the National Cancer Institute Thyroid FineNeedle Aspiration State of the Science Conference[J].Diagn Cytopathol.2008,36(6):425-437.
  • 3Ferraz C,Eszlinger M,Paschke R.Current state and future perspective of molecular diagnosis of fine-needle aspiration biopsy of thyroid nodules[J].J Clin Endocrinol Metab.2011,96(7):2016-2026.
  • 4Zhang B,Pan X,Cobb G P,et al.micro RNAs as oncogenes and tumor suppressors[J].Dev Biol.2007,302(1):1-12.
  • 5Yip L,Kelly L,Shuai Y,et al.Micro RNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma[J].Ann Surg Oncol,2011,18(7):2035-2041.
  • 6Hui A,How C,Ito E,et al.Micro-RNAs as diagnostic or prognostic markers in human epithelial malignancies[J].BMC Cancer.2011,500.
  • 7de la Chapelle A,Jazdzewski K.Micro RNAs in thyroid cancer[J].J Clin Endocrinol Metab.2011,96(11):3326-3336.
  • 8He H,Jazdzewski K,Li W,et al.The role of micro RNA genes in papillary thyroid carcinoma[J].Proc Natl Acad Sci U S A.2005,102(52):19075-19080.
  • 9Pallante P,Visone R,Ferracin M,et al.Micro RNA deregulation in human thyroid papillary carcinomas[J].Endocr Relat Cancer.2006,13(2):497-508.
  • 10Nikiforova M N,Chiosea S I,Nikiforov Y E.Micro RNA expression profiles in thyroid tumors[J].Endocr Pathol.2009,20(2):85-91.

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部